| Business Summary | | ATS
Medical,
Inc.
manufactures
and
markets
a
mechanical
bileaflet
heart
valve
with
a
unique
open
pivot
design.
The
Company's
valve
is
used
to
treat
heart
valve
failure
caused
by
the
natural
aging
process,
rheumatic
heart
disease,
prosthetic
valve
failure
and
congenital
defects.
The
Company's
valve
has
become
the
world's
most
frequently
implanted
prosthetic
heart
valve
and
is
currently
the
industry
standard.
The
ATS
heart
valve
is
designed
to
advance
the
standard
among
mechanical
heart
valves
by
incorporating
a
pivot
consisting
of
protruding
spheres
upon
which
the
leaflets
of
the
valve
pivot
to
open
and
close.
This
unique
open
pivot
has
been
designed
to
eliminate
the
cavity
associated
with
the
pivot
of
other
bileaflet
valves
and
to
improve
the
ability
of
the
blood
to
flow
through
the
valve
without
forming
clots. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | ATS
Medical,
Inc.
manufactures
and
markets
a
pyrolytic
carbon
bileaflet
mechanical
heart
valve.
The
Company
sells
the
ATS
Valve
in
international
markets
and
sponsors
clinical
trials.
For
the
six
months
ended
6/30/01,
revenues
rose
27%
to
$8.7
million.
Net
loss
totalled
$1.9
million
vs.
an
income
of
$167
thousand.
Revenues
reflect
a
higher
average
selling
price
for
the
Valve.
Loss
reflects
an
increase
in
sales
and
marketing
costs. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Manuel Villafana, 60 Chairman,
CEO, Director | $268K | -- | Richard Kramp, 55 Pres,
COO, Director | 222K | -- | John Jungbauer, 51 CFO,
VP, Treasurer | 156K | $888K | Russell Felkey, 50 Exec.
VP of Regulatory Affairs and Sec. | 197K | 854K | Frank Santiago, 49 VP,
Sales and Marketing | 154K | 328K | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|